|
|
15th
International Conference on Pharmacoepidemiology
International Society for Pharmacoepidemiology
Boston, Massachusetts, August 28, 1999
Application of New Methods to Drug Safety
Surveillance: Beyond Spontaneous Reports; Evelyn M. Rodriguez, MD, MPH Director, Division
of Drug Risk Evaluation II Office of Postmarketing Drug Risk Assessment Center for Drug
Evaluation and Research, FDA (1/12/2000)
New methods for signal detection; Ana Szarfman,
M.D., Ph.D., Medical Officer, QMR/OEB/CDER/FDA Principal investigator  (1/12/2000)
Update on the Office of Postmarketing Drug
Risk Assessment (OPDRA): Data Quality for Drug Risk Assessment; Ralph Lillie, RPh, MPH
Deputy Director, Office of Postmarketing Drug Risk Assessment (1/12/2000)
Update on the Office of Postmarketing Drug
Risk Assessment (OPDRA): New Methods to Enhance Drug Safety Surveillance; Ralph Lillie,
RPh, MPH Deputy Director, Office of Postmarketing Drug Risk Assessment (1/12/2000)
FDA/Center for Drug Evaluation and Research
Last Updated: March 08, 2001
Originator: OTCOM/DML
HTML by PKS |
